The prostate cancer drug market
Nat Rev Drug Discov
.
2021 Sep;20(9):663-664.
doi: 10.1038/d41573-021-00111-w.
Authors
Carolina do Pazo
,
Rachel M Webster
PMID:
34145436
DOI:
10.1038/d41573-021-00111-w
No abstract available
Publication types
News
MeSH terms
Antineoplastic Agents / administration & dosage*
Antineoplastic Agents / pharmacology
Drug Development*
Humans
Male
Prognosis
Prostatic Neoplasms / drug therapy*
Prostatic Neoplasms / pathology
Survival Rate
Substances
Antineoplastic Agents